Evidence map›Paper›PMID 33598259›Full record

ArticleClinical case reports2021

Addition of levosimendan to overcome acute cardiogenic shock-Paving the way for later heart transplantation-A first case report.

Christian Flottmann, Daniel Dumitrescu, Christian Sohns, Volker Rudolph, Henrik Fox

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Christian FlottmannClinic for General and Interventional Cardiology/Angiology Herz- und Diabeteszentrum NRW Ruhr-Universität Bochum Bad Oeynhausen Germany.
Daniel DumitrescuClinic for General and Interventional Cardiology/Angiology Herz- und Diabeteszentrum NRW Ruhr-Universität Bochum Bad Oeynhausen Germany.
Christian SohnsClinic for Electrophysiology Herz- und Diabeteszentrum NRW Ruhr-Universität Bochum Bad Oeynhausen Germany.
Volker RudolphClinic for General and Interventional Cardiology/Angiology Herz- und Diabeteszentrum NRW Ruhr-Universität Bochum Bad Oeynhausen Germany.
Henrik FoxHeart Failure Department Herz- und Diabeteszentrum NRW Ruhr-Universität Bochum Bad Oeynhausen Germany.ORCID https://orcid.org/0000-0002-2187-8715

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treatment of refractory cardiogenic shock has poor outcome. Levosimendan addition may help to achieve hemodynamic stabilization and improve conditions to where further treatment options such as listing for heart transplantation may become possible.

Indexed as

cardiogenic shockhypoperfusion syndromelevosimendanlow output syndromemechanical circulatory supporttransplantation

Identifiers

PMID33598259
PMCPMC7869361

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.